The choice between a brand-name and compounded GLP-1 medication comes up constantly given the cost difference involved, and it's worth breaking down specifically what stays the same and what actually changes between the two options.
What's Often the Same
When a compounding pharmacy uses the same active pharmaceutical ingredient, semaglutide or tirzepatide base compound, sourced from an FDA-registered bulk substance facility, the core active molecule is chemically the intended same compound as the brand-name product, at least in principle.
What's Genuinely Different
Compounded products are not individually FDA-reviewed and approved the way the brand-name product is, meaning there's no equivalent batch-level FDA oversight of the specific product you receive. Some compounded versions use a different salt form of the active ingredient (such as semaglutide sodium or semaglutide acetate rather than the base form used in the approved product), a distinction the FDA and manufacturers have specifically flagged as a meaningful chemical difference, not merely a technicality, since salt form can affect a compound's properties.
Legal Status Has Shifted
As discussed in this site's news coverage, the legal basis for compounding a copy of these drugs depends heavily on official shortage status, which has changed over time, meaning compounded availability isn't a fixed, permanent option in the way brand-name prescribing is.
Quality Control Differences
Brand-name manufacturing undergoes FDA facility inspection and batch-level quality requirements as a condition of approval. Compounding pharmacies operate under a different regulatory framework, USP 795/797 sterile compounding standards and state board oversight, which can still be rigorous at a well-run pharmacy, but represents a genuinely different, generally less centralized oversight structure than FDA drug manufacturing review.
Cost Difference Reflects These Differences
The often-significant price gap between compounded and brand-name versions isn't simply markup or discount, it reflects real differences in regulatory pathway, clinical trial investment, and manufacturing oversight structure, which is worth factoring into a cost comparison rather than treating price alone as the deciding factor.
The Bottom Line
Compounded and brand-name GLP-1 products can share the same core active ingredient, but they differ in regulatory review, oversight structure, and sometimes exact chemical formulation, differences worth weighing directly, alongside cost, rather than treating the two as functionally identical products with different price tags.
A Practical Checklist for Evaluating a Compounded Offer
Before accepting a compounded GLP-1 prescription, it's worth directly asking whether the pharmacy is 503A or 503B licensed and in good standing with its state board, whether the product uses the base compound or a different salt form, and whether the underlying drug is still officially listed as in shortage, questions this site's compounding and shortage guides walk through in more depth individually.